Anna Frants
Otolaryngology/Facial Plastic Surgery · Brooklyn, NYNPI 1902354889
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Galderma Laboratories, L.p. at 35.0% of the total. Reporting peaked in 2022 at $188 and has fallen 90.0% since, to $19 in 2025. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in NY, where the typical reported total is $2,391.
Across 8 payments — averaging $36.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$102
- GSK$58
- Lilly USA, LLC$33
- Checkpoint Surgical, Inc$31
- Boston Scientific$29
- Verrica Pharmaceuticals Inc.$23
- plus $15 from 1 others
What the payments were for
- Food & beverage$291100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 1 | $102 |
| GSK | 1 | $58 |
| Lilly USA, LLC | 2 | $33 |
| Checkpoint Surgical, Inc | 1 | $31 |
| Boston Scientific | 1 | $29 |
| Verrica Pharmaceuticals Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
How this compares
$291 in reported general payments places this provider in the 10th percentile of 48 otolaryngology/facial plastic surgery providers in New York.
See all otolaryngology/facial plastic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 68 | $204 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Brooklyn
- Sanjay KantuBrooklyn$2K
- Jennifer LevineNew York$454K
- Jason MocheNew York$439K
- Stephen WarmanForest Hills$50K
- Stacey SilversNew York$42K
- Dara LiottaNew York$17K
- Amar SuryadevaraSyracuse$11K
- Sean KennedyGlens Falls$10K
- Jordon GrubeAlbany$9K
- Gary SnyderPlainview$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.